PubMed:32829416 JSON TXT

The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.

projects that include this document

Unselected / annnotation		Selected / annnotation
GlyCosmos6-UBERON (0) LitCovid-GlycoBiology (0) Inflammaging (2) GlyCosmos6-docs (0) Glycosmos6-GlycoEpitope (0) GlyCosmos6-CLO (0) GlyCosmos6-Glycan-Motif-Structure (0) Glycosmos6-MAT (0) mondo_disease (1) NCBITAXON (1) sentences (1) GlyCosmos6-Glycan-Motif-Image (0) GlyCosmos6-HP (0)